4,709
Views
42
CrossRef citations to date
0
Altmetric
Letter to the Editor

Loperamide toxicokinetics: serum concentrations in the overdose setting

, &
Pages 495-496 | Received 16 Jan 2015, Accepted 03 Mar 2015, Published online: 30 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Zain Ali, Umer Shoukat, Mariya Khan, Sohaib Roomi & Waqas Ullah. (2020) ‘ Loperamide overdose induces ventricular tachycardia with catastrophic outcomes’. Journal of Community Hospital Internal Medicine Perspectives 10:3, pages 229-232.
Read now
William Eggleston, Robert Palmer, Pierre-André Dubé, Stephen Thornton, Andrew Stolbach, Diane P Calello & Jeanna M Marraffa. (2020) Loperamide toxicity: recommendations for patient monitoring and management. Clinical Toxicology 58:5, pages 355-359.
Read now
Brandon Masi Parker, Tejaus Rao, Ann Matta, Megan Quitanna, H. Neal Reynolds, Deborah M Stein & Daniel Haase. (2019) Loperamide induced cardiac arrhythmia successfully supported with veno-arterial ECMO (VA-ECMO), molecular adsorbent recirculating system (MARS) and continuous renal replacement therapy (CRRT). Clinical Toxicology 57:11, pages 1118-1122.
Read now
Justin P. Reinert & Rebecca L. Dunn. (2019) Management of overdoses of loperamide, gabapentin, and modafinil: a literature review. Expert Review of Clinical Pharmacology 12:9, pages 901-908.
Read now
Vincent R. Lee, Ariel Vera, Andreia Alexander, Bruce Ruck, Lewis S. Nelson, Paul Wax, Sharan Campleman, Jeffrey Brent & Diane P. Calello. (2019) Loperamide misuse to avoid opioid withdrawal and to achieve a euphoric effect: high doses and high risk. Clinical Toxicology 57:3, pages 175-180.
Read now
William Eggleston, Jeanna M. Marraffa & Nicholas Nacca. (2017) In response to: “Loperamide metabolite-induced cardiomyopathy and QTc prolongation”. Clinical Toxicology 55:9, pages 1023-1023.
Read now

Articles from other publishers (36)

Hua Rong Lu, Bruce P. Damiano, Mohamed Kreir, Jutta Rohrbacher, Henk van der Linde, Tamerlan Saidov, Ard Teisman & David J. Gallacher. (2023) The Potential Mechanisms behind Loperamide-Induced Cardiac Arrhythmias Associated with Human Abuse and Extreme Overdose. Biomolecules 13:9, pages 1355.
Crossref
Peter E. Wu & David N. Juurlink. (2022) Loperamide Cardiac Toxicity: Pathophysiology, Presentation, and Management. Canadian Journal of Cardiology 38:9, pages 1378-1383.
Crossref
Tochukwu Ibe, Sean Sileno & Michael F. Harrison. (2022) 24-Year-Old Man With Syncope. Mayo Clinic Proceedings 97:3, pages 620-623.
Crossref
Raunak Mohan Nair, Bahaa Abdelghaffar & Roy Chung. (2022) Loperamide Overdose With Ventricular Tachycardia Storm. American Journal of Therapeutics 29:1, pages e129-e131.
Crossref
Vivek Modi, Matthew Krinock, Ravi Desai, Steven Stevens & Sudip Nanda. (2021) Loperamide-Induced Cardiac Events: Case Reports and Review. Cureus.
Crossref
Mark Simon & John Rague. (2021) A Case Report of Torsade de Pointes and Brugada Pattern Associated with Loperamide Misuse and Supratherapeutic Loperamide Concentrations. The Journal of Emergency Medicine 61:4, pages e54-e59.
Crossref
Jessica K. Brar, Viktoriya R. Broyan, Jeffrey T. Allgaier, Larry Nye & Andrew J. Saxon. (2020) Long-term Buprenorphine Treatment for Loperamide Use Disorder: A Case Series. Journal of Addiction Medicine 14:6, pages e378-e381.
Crossref
C. James Watson, James D. Whitledge, Alexander F. Barbuto, Katherine L. Boyle & Michael Ganetsky. (2020) Toxicity of agents used for opioid withdrawal: a case-based approach. International Anesthesiology Clinics 58:2, pages 19-27.
Crossref
N E Webb, D M Wood, J C Black, E Amioka, R C Dart & P I Dargan. (2020) Non-medical use of loperamide in the UK and the USA. QJM: An International Journal of Medicine 113:1, pages 25-30.
Crossref
Jonathan D Cicci, Sarah M Jagielski, Megan M Clarke, Robert A Rayson & Matthew A Cavender. (2019) Loperamide overdose causing torsades de pointes and requiring Impella temporary mechanical support: a case report. European Heart Journal - Case Reports 3:4, pages 1-6.
Crossref
Todd Teigeler, Heather Stahura, Rizwan Alimohammad, Gautham Kalahasty, Jayanthi N. Koneru, Michael Ellenbogen, Kenneth A. Ellenbogen & Santosh K. Padala. (2019) Electrocardiographic changes in loperamide toxicity: Case report and review of literature. Journal of Cardiovascular Electrophysiology 30:11, pages 2618-2626.
Crossref
John W. Powell & Susan Erin Presnell. (2019) Loperamide as a Potential Drug of Abuse and Misuse: Fatal Overdoses at the Medical University of South Carolina. Journal of Forensic Sciences 64:6, pages 1726-1730.
Crossref
Utkarsh Kohli, Mohammad Altujjar, Rajaninder Sharma & Sohail Hassan. (2019) Wide interindividual variability in cardiovascular toxicity of loperamide: A case report and review of literature. HeartRhythm Case Reports 5:4, pages 221-224.
Crossref
Mário L de Lemos, Jolene Guenter & Victoria Kletas. (2017) Loperamide and cardiac events: Is high-dose use still safe for chemotherapy-induced diarrhea?. Journal of Oncology Pharmacy Practice 24:8, pages 634-636.
Crossref
Michael S. Toce, Peter R. Chai, Michele M. Burns & Edward W. Boyer. (2018) Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity. Journal of Medical Toxicology 14:4, pages 306-322.
Crossref
Ayodeji Okusanya & Xiaofan Li. (2018) Loperamide Abuse and Dependence: Clinical Features and Treatment Considerations. Journal of Addiction Medicine 12:6, pages 496-498.
Crossref
Asim Ahmed, Scott Freeland, Leonard Steinberg & Eric N. Prystowsky. (2018) Wide complex tachycardia and cardiomyopathy: What would you do?. Journal of Cardiovascular Electrophysiology 29:8, pages 1171-1173.
Crossref
Adrienne Hughes, Robert G. Hendrickson, Betty Chia-Chi Chen & Matthew Valento. (2018) Severe loperamide toxicity associated with the use of cimetidine to potentiate the “high”. The American Journal of Emergency Medicine 36:8, pages 1527.e3-1527.e5.
Crossref
Tamer Akel & Soad Bekheit. (2018) Loperamide cardiotoxicity: “A Brief Review”. Annals of Noninvasive Electrocardiology 23:2, pages e12505.
Crossref
Jiansong Sheng, Phu N. Tran, Zhihua Li, Sara Dutta, Kelly Chang, Thomas Colatsky & Wendy W. Wu. (2017) Characterization of loperamide-mediated block of hERG channels at physiological temperature and its proarrhythmia propensity. Journal of Pharmacological and Toxicological Methods 88, pages 109-122.
Crossref
Jessica V. Rivera, Emily Green Vance, William F. Rushton & Justin K. Arnold. (2017) Novel Psychoactive Substances and Trends of Abuse. Critical Care Nursing Quarterly 40:4, pages 374-382.
Crossref
Raphael J. Leo, Muhammad A. Ghazi & Kelly S. Jaziri. (2017) Methadone Management of Withdrawal Associated With Loperamide-related Opioid Use Disorder. Journal of Addiction Medicine 11:5, pages 402-404.
Crossref
Kenneth D. Katz, Robert D. Cannon, Matthew D. Cook, Alexandra Amaducci, Ryan Day, Joshua Enyart, Glenn Burket, Lauren Porter, Timothy Roach, Jennifer Janssen & Karl E. Williams. (2017) Loperamide-Induced Torsades de Pointes: A Case Series. The Journal of Emergency Medicine 53:3, pages 339-344.
Crossref
Peter E. Wu & David N. Juurlink. (2017) Clinical Review: Loperamide Toxicity. Annals of Emergency Medicine 70:2, pages 245-252.
Crossref
Maria Katselou, Ioannis Papoutsis, Panagiota Nikolaou, Artemisia Dona, Chara Spiliopoulou & Sotiris Athanaselis. (2017) “Poor man’s methadone” can kill the poor man. Extra-medical uses of loperamide: a review. Forensic Toxicology 35:2, pages 217-231.
Crossref
Shawna Bellew & Tyler W. Barrett. (2017) Loperamide Will Stop You Up but It Can Also Bring You Down. Annals of Emergency Medicine 69:6, pages 786-791.
Crossref
Heather Miller, Ladan Panahi, Daniel Tapia, Andrew Tran & John D. Bowman. (2017) Loperamide misuse and abuse. Journal of the American Pharmacists Association 57:2, pages S45-S50.
Crossref
Kimberley A. Swank, Eileen Wu, Cindy Kortepeter, Jana McAninch & Robert L. Levin. (2017) Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse. Journal of the American Pharmacists Association 57:2, pages S63-S67.
Crossref
Daniel R. Lasoff, Cynthia H. Koh, Bryan Corbett, Alicia B. Minns & F. Lee Cantrell. (2017) Loperamide Trends in Abuse and Misuse Over 13 Years: 2002-2015. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37:2, pages 249-253.
Crossref
William Eggleston, Kenneth H. Clark & Jeanna M. Marraffa. (2017) Loperamide Abuse Associated With Cardiac Dysrhythmia and Death. Annals of Emergency Medicine 69:1, pages 83-86.
Crossref
Noha Al-Qasmi, M. Tahir Soomro, M. Aslam, Ateeq Ur Rehman, Shahid Ali, Ekram Y. Danish, Iqbal M.I. Ismail & A. Hameed. (2016) The efficacy of the ZnO:α-Fe2O3 composites modified carbon paste electrode for the sensitive electrochemical detection of loperamide: A detailed investigation. Journal of Electroanalytical Chemistry 783, pages 112-124.
Crossref
Stanley Nattel. (2016) An Emerging Malignant Arrhythmia Epidemic Due to Loperamide Abuse. JACC: Clinical Electrophysiology 2:7, pages 790-792.
Crossref
William Eggleston, Jeanna M Marraffa, Christine M Stork, Maria Mercurio-Zappala, Mark K Su, Rachel S Wightman, Karen R Cummings & Joshua G Schier. (2016) Notes from the Field : Cardiac Dysrhythmias After Loperamide Abuse — New York, 2008–2016 . MMWR. Morbidity and Mortality Weekly Report 65:45, pages 1276-1277.
Crossref
PATRICIA VAUGHN, MICHELLE M. K. SOLIK, SHIV BAGGA & BENZY J. PADANILAM. (2016) Electrocardiographic Abnormalities, Malignant Ventricular Arrhythmias, and Cardiomyopathy Associated With Loperamide Abuse. Journal of Cardiovascular Electrophysiology 27:10, pages 1230-1233.
Crossref
Charles W. O’Connell, Amir A. Schricker, Aaron B. Schneir, Imir G. Metushi, Ulrika Birgersdotter-Green & Alicia B. Minns. (2016) High-dose loperamide abuse–associated ventricular arrhythmias. HeartRhythm Case Reports 2:3, pages 232-236.
Crossref
Kirby Welston & Dianne May. 2016. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 379 393 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.